Detalhe da pesquisa
1.
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across Severe Acute Respiratory Syndrome Coronavirus 2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.
Clin Infect Dis
; 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38445721
2.
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination.
J Infect Dis
; 227(5): 651-662, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402141
3.
Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials.
Clin Infect Dis
; 76(12): 2077-2086, 2023 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809473
4.
Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study.
Clin Infect Dis
; 76(3): e172-e178, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869843
5.
Clinical Impact of Polymerase Chain Reaction-Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study.
Clin Infect Dis
; 77(1): 38-45, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36905147
6.
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
PLoS Med
; 20(1): e1004159, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36608645
7.
High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients.
J Antimicrob Chemother
; 78(7): 1644-1648, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248664
8.
Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients.
Clin Infect Dis
; 74(7): 1271-1274, 2022 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293119
9.
Significant Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Care in Hospitals Affecting the First Pillar of the HIV Care Continuum.
Clin Infect Dis
; 74(3): 521-524, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993276
10.
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
PLoS Med
; 19(10): e1003979, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301821
11.
Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19.
J Clin Immunol
; 42(2): 232-239, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767118
12.
Incidence of HCV Reinfection Among HIV-Positive MSM and Its Association With Sexual Risk Behavior: A Longitudinal Analysis.
Clin Infect Dis
; 73(3): 460-467, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32459339
13.
Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis1.
Emerg Infect Dis
; 27(11): 2892-2898, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519638
14.
Frequency of Positive Aspergillus Tests in COVID-19 Patients in Comparison to Other Patients with Pulmonary Infections Admitted to the Intensive Care Unit.
J Clin Microbiol
; 59(3)2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277340
15.
When to change treatment of acute invasive aspergillosis: an expert viewpoint.
J Antimicrob Chemother
; 77(1): 16-23, 2021 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34508633
16.
Future challenges and chances in the diagnosis and management of invasive mould infections in cancer patients.
Med Mycol
; 59(1): 93-101, 2021 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898264
17.
Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013-2018.
Emerg Infect Dis
; 26(7): 1447-1455, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32568033
18.
Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
PLoS Med
; 17(5): e1003101, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32407386
19.
Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B.
Med Mycol
; 58(7): 874-880, 2020 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31965178
20.
High-dose posaconazole for azole-resistant aspergillosis and other difficult-to-treat mould infections.
Mycoses
; 63(2): 122-130, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31660650